Innovator’s Pitch Challenge

Voximetry is a pre-revenue Healthtech software company entering the commercialization phase. Our product is currently under FDA review and we anticipate FDA market clearance in July 2022. Our core competence is implementing complex medical physics algorithms on high-speed Graphics Processing Units (GPUs). Currently focused on a prostate cancer targeted therapy – radiopharmaceutical therapy – Voximetry provides best-in-class patient-specific treatment plans in this rapidly emerging market (39% CAGR).